Inotek Pharma (ITEK) Tops Q2 EPS by 7c
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Inotek Pharma (NASDAQ: ITEK) reported Q2 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- Nu Skin Enterprises (NUS) Guides FY17 Revenue, EPS Below Views
- PriceSmart (PSMT) Comps Fell 0.2% in November 2016
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!